Literature DB >> 24862260

Regulation of cancer metabolism by oncogenes and tumor suppressors.

Raffaella Iurlaro1, Clara Lucía León-Annicchiarico1, Cristina Muñoz-Pinedo2.   

Abstract

Cell proliferation requires the coordination of multiple signaling pathways as well as the provision of metabolic substrates. Nutrients are required to generate such building blocks and their form of utilization differs to significant extents between malignant tissues and their nontransformed counterparts. Thus, oncogenes and tumor suppressor genes regulate the proliferation of cancer cells also by controlling their metabolism. Here, we discuss the central anabolic functions of the signaling pathways emanating from mammalian target of rapamycin, MYC, and hypoxia-inducible factor-1. Moreover, we analyze how oncogenic proteins like phosphoinositide-3-kinase, AKT, and RAS, tumor suppressors such as phosphatase and tensin homolog, retinoblastoma, and p53, as well as other factors associated with the proliferation or survival of cancer cells, such as NF-κB, regulate cellular metabolism.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKT; HIF-1; MYC; RAS; mTOR; p53

Mesh:

Substances:

Year:  2014        PMID: 24862260     DOI: 10.1016/B978-0-12-416618-9.00003-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  36 in total

Review 1.  Signaling Pathways and Emerging Therapies in Multiple Myeloma.

Authors:  Vijay Ramakrishnan; Anita D'Souza
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

Review 2.  Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.

Authors:  Giorgia Zadra; Massimo Loda
Journal:  Cold Spring Harb Perspect Med       Date:  2018-10-01       Impact factor: 6.915

3.  Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids.

Authors:  Shibdas Banerjee; Richard N Zare; Robert J Tibshirani; Christian A Kunder; Rosalie Nolley; Richard Fan; James D Brooks; Geoffrey A Sonn
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-14       Impact factor: 11.205

4.  PET Imaging on Dynamic Metabolic Changes after Combination Therapy of Paclitaxel and the Traditional Chinese Medicine in Breast Cancer-Bearing Mice.

Authors:  Yao Chen; Ling Wang; Hao Liu; Fahuan Song; Caiyun Xu; Kai Zhang; Qing Chen; Shuang Wu; Yunqi Zhu; Ying Dong; Min Zhou; Hong Zhang; Mei Tian
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

5.  Mitochondrial transcription factor B1 promotes the progression of hepatocellular carcinoma via enhancing aerobic glycolysis.

Authors:  Jiao Mu; Yiyuan Tian; Fengzhou Liu; Zijun Wang; Rui Tan; Bei Zhang; Penghe Quan; Hongxin Zhang; Jingyue Yang; Peng Yuan
Journal:  J Cell Commun Signal       Date:  2021-11-25       Impact factor: 5.908

Review 6.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

Review 7.  Cancer's Fuel Choice: New Flavors for a Picky Eater.

Authors:  Gina M DeNicola; Lewis C Cantley
Journal:  Mol Cell       Date:  2015-11-19       Impact factor: 17.970

Review 8.  Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take.

Authors:  Patricia Altea-Manzano; Alejandro M Cuadros; Lindsay A Broadfield; Sarah-Maria Fendt
Journal:  EMBO Rep       Date:  2020-09-23       Impact factor: 8.807

9.  The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.

Authors:  Katarzyna Starska; Ewa Forma; Maria Nowacka-Zawisza; Iwona Lewy-Trenda; Piotr Ciesielski; Wioletta Pietruszewska; Michał Skóra; Magdalena Bryś
Journal:  Tumour Biol       Date:  2015-10-27

10.  LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response.

Authors:  Ji Hee Ha; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Mingda Yan; Jeremy D Ward; Kar-Ming Fung; Katherine Moxley; Anil K Sood; Ciro Isidoro; Priyabrata Mukherjee; Yong Sang Song; Danny N Dhanasekaran
Journal:  Cancer Res       Date:  2018-01-31       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.